Pompe Disease (LOPD)

Disease Overview

Pompe Disease is a rare, inherited metabolic disorder characterized by the progressive accumulation of glycogen in cells due to a deficiency of the enzyme acid alpha-glucosidase (GAA). Late-Onset Pompe Disease (LOPD) typically manifests in childhood, adolescence, or adulthood, causing progressive muscle weakness and respiratory complications.

Disease Category

Genetic Disorder
Metabolic Disorder
Neuromuscular Disorder
Lysosomal Storage Disease

Synonyms

Glycogen Storage Disease Type II
Acid Maltase Deficiency
Glycogenosis Type II
Alpha-1,4-Glucosidase Deficiency

Signs & Symptoms

Progressive muscle weakness, particularly in legs and trunk
Respiratory insufficiency
Difficulty walking, running, or climbing stairs
Chronic fatigue
Muscle pain and cramps
Potential cardiac involvement
Respiratory muscle weakness
Sleep apnea
Reduced exercise tolerance

Causes

Autosomal recessive genetic inheritance
Mutations in the GAA gene on chromosome 17
Deficiency or dysfunction of acid alpha-glucosidase enzyme
Impaired glycogen breakdown in lysosomal cells
Accumulation of glycogen in muscle tissues

Affected Populations

Prevalence: Approximately 1 in 40,000 individuals globally
Affects both males and females
Occurs across various ethnic groups
Symptoms typically emerge in childhood or adulthood
No significant geographical or racial predisposition

Disorders with Similar Symptoms

Other Glycogen Storage Diseases
Muscular Dystrophies
Polymyositis
Amyotrophic Lateral Sclerosis (ALS)
Metabolic Myopathies
Mitochondrial Disorders

Diagnosis

Comprehensive clinical evaluation
Enzyme activity assay
Genetic testing for GAA gene mutations
Muscle biopsy
Electromyography (EMG)
Pulmonary function testing
Creatine kinase level assessment
Genetic counseling

Standard Therapies

Enzyme Replacement Therapy (ERT)
Respiratory support interventions
Physical therapy
Occupational therapy
Nutritional counseling
Assistive devices
Ventilatory support
Regular monitoring of cardiac and respiratory functions

Clinical Trials and Studies

Ongoing research into:
- Gene therapy
- Advanced enzyme replacement techniques
- Novel therapeutic approaches
- Long-term treatment strategies
Registered clinical trials available on ClinicalTrials.gov

References

National Institutes of Health (NIH)
Genetics Home Reference
Published medical literature in peer-reviewed journals
International Pompe Association research publications

Programs & Resources

Genetic and Rare Diseases Information Center (GARD)
National Organization for Rare Disorders (NORD)
International Pompe Association (IPA)
Muscular Dystrophy Association (MDA)
Patient support groups
Online medical resources

Complete Report

Pompe Disease represents a complex genetic disorder requiring comprehensive, multidisciplinary management. While current treatments focus on symptom management and enzyme replacement, ongoing research offers hope for more advanced therapeutic interventions. Patients benefit from early diagnosis, personalized treatment plans, and comprehensive support systems.